Publicaciones Similares
Guidelines Osteoporosis
PorSadenoTreatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update from the American College of Physicians Descarga aquí el artículo
Evidencias de los nuevos tratamientos para el colesterol
PorSadenoClinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial LDL cholesterol is a well established risk factor for atherosclerotic cardiovascular disease. How much one should or safely can lower this risk factor remains debated. We aimed to explore the relationship between progressively lower…
Artículo Tiroides y embarazo y posparto
PorSadenoEstá disponible para descarga el artículo sobre Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum, de la Asociación Americana de Tiroides. Descárgalo aquí
Standards or Medical Care in Diabetes 2017
PorSadenoConsulta aquí el artículo Standards or Medical Care in Diabetes 2017, publicado por la American Diabetes Association
Video resumen de la Jornada Lipid Expert Day
PorSadenoEn el siguiente video podrá ver un completo resumen de la Jornada Lipid Expert Day, celebrada e pasado 6 de junio en el Palacio de Congresos y Exposiciones Ciudad de Oviedo. Durante la Jornada se analizaron temas de diversa índole como, Técnicas de imagen para valoración de la aterosclerosis; que corrió a cargo del Dr. Leopoldo Pérez…
Evolocumab and Clinical Outcomes in Patients with Card. Disease
PorSadenoDescargue el artículo completo ABSTRACT BACKGROUND Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin–kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by approximately 60%. Whether it prevents cardiovascular events is uncertain. METHODS We conducted a randomized, double-blind, placebo-controlled trial involving 27,564 patients with atherosclerotic cardiovascular disease and LDL cholesterol levels…
